Clinical trial · Interventional
Photodynamic Therapy in Treatment of Verrucae
PHOTODYNAMIC THERAPY USING METHYLENE BLUE AND INTENSE PULSED LIGHT VERSUS INTENSE PULSED LIGHT ALONE IN TREATMENT OF VERRUCA :A RANDOMIZED CONTROLLED STUDY
NCT04620785CI-TRIAL-00052903unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To assess the efficacy (clinically and dermoscopically) and safety of photodynamic therapy using intralesional injection of 4% methylene blue solution as a photosensitizer with IPL versus IPL only in treatment of warts.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Verruca Vulgaris | Verruca Vulgaris | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| IPL | Other | — | UNRESOLVED |
| methylene blue / IPL | Other | — | UNRESOLVED |
| saline | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- methylene blue/IPL
- description
- will undergo photodynamic therapy using intralesional 4%methylene blue solution ,after a period of 15 minutes the patient will be subjected to IPL session. This will be repeated biweekly until complete clearance of the lesion or a maximum four sessions.
- interventionNames
- Other: methylene blue / IPL
- type
- EXPERIMENTAL
- label
- IPL
- description
- will undergo biweekly IPL sessions only until complete clearance of the lesion or a maximum four sessions.
- interventionNames
- Other: IPL
- type
- PLACEBO_COMPARATOR
- label
- saline
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 16 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age:Above 16 years old. 2. Sex:Both males and female patients. 3. Clinically and dermoscopically documented verruca. 4. No verruca treatment in the last 2 weeks. Exclusion Criteria: 1. History of photosensitivity disorder. 2. Pregnant and lactating females. 3. Diseases with risk of koebnerization e.g. Psoriasis and Lichen planus. 4. Anogenital warts. 5. Warts on head and neck.
References
Publications (0)
Data not yet available
No reference posted for this study.